Skip to main content

Table 1 Partial characterization of CMCNPs and CHNPs (n = 3)

From: Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics

Nanoparticles group

CMC, CH:MMA Molar ratio (w/w)

Initiator dosage(mg)

Particle size (nm)

Polydispersity Index

Zeta potential (mV)

CMCNPs (-40)

3:1

150

163.6 ± 7.9

0.081 ± 0.006

− 18.80 ± 3.2

CMCNPs (-30)

1:1

30

166.7 ± 7.5

0.066 ± 0.011

− 27.97 ± 4.0

CMCNPs (-20)

1:5

30

169.2 ± 8.9

0.108 ± 0.006

− 43.40 ± 3.9

CHNPs (+20)

1:1

300

144.3 ± 4.4

0.075 ± 0.007

16.09 ± 5.1

CHNPs (+30)

1:1

70

158.3 ± 5.0

0.006 ± 0.002

31.39 ± 4.2

CHNPs (+40)

1:4

50

144.9 ± 5.7

0.070 ± 0.015

40.27 ± 3.8